Trends in use of medical abortion in the United States: Reanalysis of surveillance data from the Centers for Disease Control and Prevention, 2001-2008

Contraception

Volumn 86, Issue 6, 2012, Pages 746-751

  Pazol, Karen ^a   Creanga, Andreea A ^a   Zane, Suzanne B ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Early medical abortion; Mifepristone; Surveillance

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ACCURACY; ARTICLE; DATA ANALYSIS; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEDICAL ABORTION; TREND STUDY; UNITED STATES;

ABORTIFACIENT AGENTS; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; HISTORY, 21ST CENTURY; HUMANS; MIFEPRISTONE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PUBLIC HEALTH SURVEILLANCE; UNITED STATES;

EID: 84869085946     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.05.023     Document Type: Article

References (33)

1. B. Jordan, and W.C. Shields Happy anniversary mifepristone: a decade of promise and challenges Contraception 82 2010 219 220
2. H.D. Boonstra Mifepristone in the United States: status and future Guttmacher Rep Public Policy 5 2002 4 7
3. L.B. Finer, and J. Wei Effect of mifepristone on abortion access in the United States Obstet Gynecol 114 2009 623 630
4. K. Pazol, S.B. Zane, W.Y. Parker, L.R. Hall, C.J. Berg, and D.A. Cook Abortion surveillance - United States, 2008 MMWR Surveill Summ 60 2011 1 41
5. R.K. Jones, and K. Kooistra Abortion incidence and access to services in the United States, 2008 Perspect Sex Reprod Health 43 2011 41 50
6. Guttmacher Institute State policies in brief: abortion reporting requirements Accessed 5/17/2012 at: http://www.guttmacher.org/statecenter/spibs/ spib-ARR.pdf
7. R. Saul Abortion reporting in the United States: an examination of the federal-state partnership Fam Plann Perspect 30 1998 244 247
8. C. Yunzal-Butler, J. Sackoff, and W. Li Medication abortions among New York City residents, 2001-2008 Perspect Sex Reprod Health 43 2011 218 223
9. S.J. Ventura, J.C. Abma, W.D. Mosher, and S.K. Henshaw Estimated pregnancy rates by outcome for the United States, 1990-2004 2008 US Department of Health and Human Services, CDC, National Center for Health Statistics Hyattsville, MD (National vital statistics reports; vol 56, no. 15)
10. Henshaw SK, Van Vort J. Abortion services in the United States, 1991 and 1992. Fam Plann Perspect 1994;26:100-6, 12.
11. B. Winikoff, D. Hassoun, and H. Bracken Introduction and provision of medical abortion: a tale of two countries in which technology is necessary but not sufficient Contraception 83 2011 322 329
12. ACOG Committee ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists Obstet Gynecol 106 2005 871 882
13. R.K. Jones, M.R. Zolna, S.K. Henshaw, and L.B. Finer Abortion in the United States: incidence and access to services, 2005 Perspect Sex Reprod Health 40 2008 6 16
14. R.K. Jones, and S.K. Henshaw Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden Perspect Sex Reprod Health 34 2002 154 161 (Pubitemid 36067314)
15. C. Hammond Recent advances in second-trimester abortion: an evidence-based review Am J Obstet Gynecol 200 2009 347 356
16. N. Kapp, and H. von Hertzen Medical methods to induce abortion in the second trimester M. Paul, E.S. Lichtenberg, L. Borgatta, D.A. Grimes, P.G. Stubblefield, M.D. Creinin, Management of unintended and abnormal pregnancy: comprehensive abortion care 2009 Blackwell Publishing West Sussex 178 192
17. L. Borgatta, N. Kapp Society of Family Planning Clinical guidelines. Labor induction abortion in the second trimester Contraception 84 2011 4 18
18. Guttmacher Institute Medication abortion Accessed 5/17/2012 at: http://www.guttmacher.org/statecenter/updates/index.html#MedicationAb 2011
19. T. Joyce The supply-side economics of abortion N Engl J Med 365 2011 1466 1469
20. C.E. Dehlendorf, and K. Grumbach Medical liability insurance as a barrier to the provision of abortion services in family medicine Am J Public Health 98 2008 1770 1774
21. D. Grossman, K. Grindlay, T. Buchacker, K. Lane, and K. Blanchard Effectiveness and acceptability of medical abortion provided through telemedicine Obstet Gynecol 118 2011 296 303
22. J. Yarnall, Y. Swica, and B. Winikoff Non-physician clinicians can safely provide first trimester medical abortion Reprod Health Matters 17 2009 61 69
23. Guttmacher Institute State policies in brief: an overview of abortion laws Accessed 3/17/2012 at: http://www.guttmacher.org/statecenter/spibs/spib- OAL.pdf 2012
24. M. Creinin, and K. Gemzell-Danielsson Medical abortion early in pregnancy M. Paul, E.S. Lichtenberg, L. Borgatta, D.A. Grimes, P.G. Stubblefield, M.D. Creinin, Management of unintended and abnormal pregnancy: comprehensive abortion care 2009 Blackwell Publishing West Sussex 111 134
25. N.T. Ngoc, J. Blum, and S. Raghavan Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone Contraception 83 2011 410 417
26. L.D. Elam-Evans, L.T. Strauss, and J. Herndon Abortion surveillance - United States, 2000 MMWR Surveill Summ 52 2003 1 34
27. S.K. Henshaw, and L.B. Finer The accessibility of abortion services in the United States, 2001 Perspect Sex Reprod Health 35 2003 16 24 (Pubitemid 36187424)
28. A.A. Boersma, B. Meyboom-de Jong, and G. Kleiverda Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curacao Eur J Contracept Reprod Health Care 16 2011 61 66
29. H. Bracken, N.T. Ngoc, and E. Schaff Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion Obstet Gynecol 109 2007 895 901 (Pubitemid 46559077)
30. O. Garbin, C. Vayssiere, K. Bettahar-Lebugle, and I. Nisand Consistency of medical abortion efficacy from 5 through 14 weeks' gestation Eur J Obstet Gynecol Reprod Biol 129 2006 36 40 (Pubitemid 44637157)
31. H. Hamoda, P.W. Ashok, G.M. Flett, and A. Templeton A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation BJOG 112 2005 1102 1108 (Pubitemid 41632666)
32. H. Hamoda, P.W. Ashok, G.M. Flett, and A. Templeton Medical abortion at 9-13 weeks' gestation: a review of 1076 consecutive cases Contraception 71 2005 327 332 (Pubitemid 40602308)
33. M. Lokeland, O.E. Iversen, G.S. Dahle, M.H. Nappen, L. Ertzeid, and L. Bjorge Medical abortion at 63 to 90 days of gestation Obstet Gynecol 115 2010 962 968